HealthTech Platform

Updated:

Medalogix

Intelligent care coordination software for home-based care providers. Unify clinical data, streamline workflows, and access real-time insights with Mosai.

Medalogix logo

Medalogix

Intelligent care coordination software for home-based care providers. Unify clinical data, streamline workflows, and access real-time insights with Mosai.

General information

Firm type

HealthTech Platform

Location

Region

North America

Country

United States

City

Nashville

Corporate office

401 Commerce St Suite 360, Nashville, Tennessee 37219, United States

Additional offices

Jacksonville, FL, United States

Principals

Elliott Wood

CEO

Scott Hampel

President

Laura Brinkoetter

Chief Product Officer

Derek Frame

Chief Information Officer

Matt Obringer

Chief of Staff

Jason Schoepfer

Chief Financial Officer

Stephen Snook

Chief Revenue Officer

Lani Williams

Chief People Officer

Sector focus

Digital Health

Frequently asked questions

Who runs product and investment decisions at Medalogix?

CEO Elliott Wood sets strategic direction for Mosai, the merged entity of Medalogix and Forcura, in partnership with the Board of Directors. CPO Laura Brinkoetter leads product innovation, with a background in e-commerce and health-tech product experiences. The leadership team includes CFO Jason Schoepfer, who previously advised technology founders on M&A transactions at Harbor View Advisors.

How does Medalogix source and integrate clinical data?

The Mosai platform integrates directly with major home health and hospice EHRs, including Homecare Homebase, MatrixCare, and Axxess, to unify fragmented patient records. It serves as an overlay that ingests clinical data, applies machine learning for predictive insights, and feeds recommendations back into existing provider workflows. This approach avoids requiring providers to replace their primary documentation system.

What is the relationship between Medalogix and Forcura?

In 2024, Medalogix and Forcura merged to form Mosai, a single brand offering an end-to-end post-acute care platform. The union combines Medalogix's predictive analytics and clinical management tools with Forcura's referral intake and care coordination software. The combined executive team reflects leadership from both legacy organizations, with CEO Elliott Wood coming from Medalogix and CFO Jason Schoepfer from Forcura.

Which care settings does Medalogix serve?

Medalogix, now Mosai, focuses on home-based care providers across home health, hospice, and physician practices. The platform supports the full patient journey from initial referral and admission through ongoing clinical management and coordination with external physicians and payers. Its tools are designed specifically for the post-acute, at-home care ecosystem rather than hospital inpatient settings.

What compliance and security standards does the Medalogix platform hold?

The Mosai platform, which incorporates Medalogix technology, maintains HIPAA, HITRUST, and AICPA SOC certifications. These credentials reflect adherence to data security frameworks for handling protected health information in the cloud. The certifications are consistent with enterprise requirements for large home-health chains processing millions of patient records daily.

Does Medalogix participate in any M&A or capital markets activity?

Medalogix merged with Forcura in 2024 to form Mosai, a strategic combination that consolidated two parallel software paths in post-acute care. The executive team includes CFO Jason Schoepfer, whose background includes executing buy- and sell-side healthcare M&A transactions. However, the firm has not disclosed current fund commitments or external investment vehicles.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles